Login
EBOS Group set to bolster healthcare portfolio
EBOS Group is looking to extend its existing portfolio of healthcare, pharmaceutical and animal care businesses in Australia and New Zealand by proposing an acquisition of the nation’s largest provider of outsourced pharmacy services.
Emma Musgrave
Firms: Allens (EBOS Group); Maddocks (HPS)
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: EBOS Group Limited (EBOS) has been advised on the proposed purchase of HPS.
Value: Undisclosed
Area: M&A
Key players: The Allens legal team was led by corporate partner Emin Altiparmak, with support from partners Mark Malinas, Michael Park and Michael Graves.
The team was assisted by managing associates Rosannah Healy and Ric Morgan, senior associate Jonathan Hoe, associate Laura Miller, lawyers Karina Plain, Emily Rothfield and Leah Wickham, and law graduate Emma Moore.
Deal significance: According to a statement from Allens, the acquisition of HPS from Blue Sky Private Equity and a number of management shareholders is an important strategic investment for EBOS, boosting its existing Australian hospital business and providing a new platform for EBOS to expand.
“We are delighted to be able to help EBOS with its successful bid for the HPS business,” Mr Altiparmak said.
“The acquisition adds to EBOS’ existing portfolio of healthcare, pharmaceutical and animal care businesses in Australia and New Zealand, and we look forward to seeing EBOS continue to support the growth of the HPS business.”
Mr Malinas noted that the acquisition highlights the continued strength of M&A activity in the healthcare sector.
“The Australian healthcare sector remains a key target for sponsors and strategic buyers,” he said.
“In this case it was private equity selling to a strategic buyer. Earlier in the week we saw private equity acquire Icon Cancer Centres. We see that trend of M&A activity in healthcare assets continuing.”
